acquired
Stage
1
Investors
About
InDevR develops multiplexed microarray-based analytical assays and platforms that support development, optimization, and manufacturing quality control of various vaccine types, including mRNA, protein-based, viral vector, polysaccharide, and conjugate vaccines.
Explore InDevR's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.